In the present study, we demonstrated that hypoxic HNSCC cell-derived sEVs induce cell invasion from the primary tumor and adhesion of non-hypoxic HNSCC cells on the second lesion site by delivering LOXL2. Here, LOXL2 is linked to head and neck squamous cell carcinoma.